Cargando…
MiR-1 downregulation correlates with poor survival in clear cell renal cell carcinoma where it interferes with cell cycle regulation and metastasis
MicroRNAs (miRNA) that are strongly implicated in carcinogenesis have recently reshaped our understanding of the role of noncoding RNAs. Here, we focused on the function and molecular mechanism of miR-1 and its potential clinical application in clear cell renal cell carcinoma (ccRCC). First, miR-1 w...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4537008/ https://www.ncbi.nlm.nih.gov/pubmed/26036633 |
_version_ | 1782385830714671104 |
---|---|
author | Xiao, Haibing Zeng, Jin Li, Heng Chen, Ke Yu, Gan Hu, Junhui Tang, Kun Zhou, Hui Huang, Qihong Li, Anping Li, Yi Ye, Zhangqun Wang, Ji Xu, Hua |
author_facet | Xiao, Haibing Zeng, Jin Li, Heng Chen, Ke Yu, Gan Hu, Junhui Tang, Kun Zhou, Hui Huang, Qihong Li, Anping Li, Yi Ye, Zhangqun Wang, Ji Xu, Hua |
author_sort | Xiao, Haibing |
collection | PubMed |
description | MicroRNAs (miRNA) that are strongly implicated in carcinogenesis have recently reshaped our understanding of the role of noncoding RNAs. Here, we focused on the function and molecular mechanism of miR-1 and its potential clinical application in clear cell renal cell carcinoma (ccRCC). First, miR-1 was significantly downregulated in 87.8% renal cancer samples compared with corresponding noncancerous tissues (NCT), which was significantly associated with clinical stage, T classification and poor overall survival. Functional study demonstrated that enforced overexpression of miR-1 in renal cancer cells inhibited proliferation and metastasis in vitro and in vivo. Conversely, miR-1 inhibitor silencing miR-1 expression promoted cell proliferation and metastasis in ccRCC. CDK4, CDK6, Caprin1 and Slug were each directly targeted for inhibition by miR-1 and restoring their expression reversed miR-1-mediated inhibition of cell cycle progression and metastasis. Taken together, our findings established a tumor suppressive role for miR-1 in the progression of ccRCC by targeting CDK4, CDK6, Caprin1 and Slug and suggested miR-1 can be served as a novel potential therapeutic target for ccRCC. |
format | Online Article Text |
id | pubmed-4537008 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Impact Journals LLC |
record_format | MEDLINE/PubMed |
spelling | pubmed-45370082015-08-26 MiR-1 downregulation correlates with poor survival in clear cell renal cell carcinoma where it interferes with cell cycle regulation and metastasis Xiao, Haibing Zeng, Jin Li, Heng Chen, Ke Yu, Gan Hu, Junhui Tang, Kun Zhou, Hui Huang, Qihong Li, Anping Li, Yi Ye, Zhangqun Wang, Ji Xu, Hua Oncotarget Research Paper MicroRNAs (miRNA) that are strongly implicated in carcinogenesis have recently reshaped our understanding of the role of noncoding RNAs. Here, we focused on the function and molecular mechanism of miR-1 and its potential clinical application in clear cell renal cell carcinoma (ccRCC). First, miR-1 was significantly downregulated in 87.8% renal cancer samples compared with corresponding noncancerous tissues (NCT), which was significantly associated with clinical stage, T classification and poor overall survival. Functional study demonstrated that enforced overexpression of miR-1 in renal cancer cells inhibited proliferation and metastasis in vitro and in vivo. Conversely, miR-1 inhibitor silencing miR-1 expression promoted cell proliferation and metastasis in ccRCC. CDK4, CDK6, Caprin1 and Slug were each directly targeted for inhibition by miR-1 and restoring their expression reversed miR-1-mediated inhibition of cell cycle progression and metastasis. Taken together, our findings established a tumor suppressive role for miR-1 in the progression of ccRCC by targeting CDK4, CDK6, Caprin1 and Slug and suggested miR-1 can be served as a novel potential therapeutic target for ccRCC. Impact Journals LLC 2015-04-23 /pmc/articles/PMC4537008/ /pubmed/26036633 Text en Copyright: © 2015 Xiao et al. http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Paper Xiao, Haibing Zeng, Jin Li, Heng Chen, Ke Yu, Gan Hu, Junhui Tang, Kun Zhou, Hui Huang, Qihong Li, Anping Li, Yi Ye, Zhangqun Wang, Ji Xu, Hua MiR-1 downregulation correlates with poor survival in clear cell renal cell carcinoma where it interferes with cell cycle regulation and metastasis |
title | MiR-1 downregulation correlates with poor survival in clear cell renal cell carcinoma where it interferes with cell cycle regulation and metastasis |
title_full | MiR-1 downregulation correlates with poor survival in clear cell renal cell carcinoma where it interferes with cell cycle regulation and metastasis |
title_fullStr | MiR-1 downregulation correlates with poor survival in clear cell renal cell carcinoma where it interferes with cell cycle regulation and metastasis |
title_full_unstemmed | MiR-1 downregulation correlates with poor survival in clear cell renal cell carcinoma where it interferes with cell cycle regulation and metastasis |
title_short | MiR-1 downregulation correlates with poor survival in clear cell renal cell carcinoma where it interferes with cell cycle regulation and metastasis |
title_sort | mir-1 downregulation correlates with poor survival in clear cell renal cell carcinoma where it interferes with cell cycle regulation and metastasis |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4537008/ https://www.ncbi.nlm.nih.gov/pubmed/26036633 |
work_keys_str_mv | AT xiaohaibing mir1downregulationcorrelateswithpoorsurvivalinclearcellrenalcellcarcinomawhereitinterfereswithcellcycleregulationandmetastasis AT zengjin mir1downregulationcorrelateswithpoorsurvivalinclearcellrenalcellcarcinomawhereitinterfereswithcellcycleregulationandmetastasis AT liheng mir1downregulationcorrelateswithpoorsurvivalinclearcellrenalcellcarcinomawhereitinterfereswithcellcycleregulationandmetastasis AT chenke mir1downregulationcorrelateswithpoorsurvivalinclearcellrenalcellcarcinomawhereitinterfereswithcellcycleregulationandmetastasis AT yugan mir1downregulationcorrelateswithpoorsurvivalinclearcellrenalcellcarcinomawhereitinterfereswithcellcycleregulationandmetastasis AT hujunhui mir1downregulationcorrelateswithpoorsurvivalinclearcellrenalcellcarcinomawhereitinterfereswithcellcycleregulationandmetastasis AT tangkun mir1downregulationcorrelateswithpoorsurvivalinclearcellrenalcellcarcinomawhereitinterfereswithcellcycleregulationandmetastasis AT zhouhui mir1downregulationcorrelateswithpoorsurvivalinclearcellrenalcellcarcinomawhereitinterfereswithcellcycleregulationandmetastasis AT huangqihong mir1downregulationcorrelateswithpoorsurvivalinclearcellrenalcellcarcinomawhereitinterfereswithcellcycleregulationandmetastasis AT lianping mir1downregulationcorrelateswithpoorsurvivalinclearcellrenalcellcarcinomawhereitinterfereswithcellcycleregulationandmetastasis AT liyi mir1downregulationcorrelateswithpoorsurvivalinclearcellrenalcellcarcinomawhereitinterfereswithcellcycleregulationandmetastasis AT yezhangqun mir1downregulationcorrelateswithpoorsurvivalinclearcellrenalcellcarcinomawhereitinterfereswithcellcycleregulationandmetastasis AT wangji mir1downregulationcorrelateswithpoorsurvivalinclearcellrenalcellcarcinomawhereitinterfereswithcellcycleregulationandmetastasis AT xuhua mir1downregulationcorrelateswithpoorsurvivalinclearcellrenalcellcarcinomawhereitinterfereswithcellcycleregulationandmetastasis |